Filing Flows › Sanara MedTech (SMTI) › How it makes money
How Sanara MedTech (SMTI) makes money
Sanara MedTech (SMTI) made $28.1M of revenue in the second quarter 2026 (Q2 2026), +9% from a year earlier. Soft Tissue Repair Products brought in $25.2M (90%); Bone Fusion Products brought in $2.9M (10%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Soft Tissue Repair Products | $25.2M | 89.7% | +1% | +11% |
| Bone Fusion Products | $2.9M | 10.3% | +1% | -8% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $28.1M | 100.0% |
| Operating cash flow | $2.0M | 7.2% |
| Free cash flow | $2.0M | 7.2% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $28.1M | +9% |
| Q1 2026 | $27.8M | +19% |
| Q4 2025 | $27.5M | +5% |
| Q3 2025 | $26.3M | +22% |
| Q2 2025 | $25.8M | +28% |
| Q1 2025 | $23.4M | +26% |
| Q4 2024 | $26.3M | +49% |
From Sanara MedTech's 10-Q filed Aug 11, 2026 (on EDGAR).
Questions
How does Sanara MedTech make money?
Sanara MedTech (SMTI) made $28.1M of revenue in the second quarter 2026 (Q2 2026), +9% from a year earlier. Soft Tissue Repair Products brought in $25.2M (90%); Bone Fusion Products brought in $2.9M (10%).
What is Sanara MedTech's biggest business?
Soft Tissue Repair Products: $25.2M in the second quarter 2026, 90% of revenue, +11% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.